List of insiders holdings for Mineralys Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director | 2025-03-17 19:58:15 | 6,287,597 0 | 6,287,597 | Form 13D |
Samsara BioCapital GP LLC Samsara BioCapital L.P. 10% Owner | 2025-03-17 21:06:42 | 5,736,305 0 | 5,736,305 | Form 13D |
AKKARAJU SRINIVAS Director | 2025-03-17 21:04:15 | 0 5,674,916 | 5,674,916 | Form 4 |
HBM Healthcare Investments (Cayman) Ltd. 10% Owner | 2024-11-13 16:19:46 | 2,246,332 0 | 2,246,332 | Form 13G |
Congleton Jon Chief Executive Officer | 2025-02-24 18:58:52 | 570,000 0 | 570,000 | Form 4 |
Rodman David Malcom Chief Medical Officer | 2025-04-03 17:36:57 | 230,978 0 | 230,978 | Form 4 |
Levy Adam Scott CFO and Secretary | 2025-02-24 18:59:52 | 170,000 0 | 170,000 | Form 4 |
Slingsby Brian Taylor Catalys Pacific Fund LP Director 10% Owner | 2025-02-24 18:59:23 | 32,900 32,900 | 65,800 | Form 4 |
Asam Alexander Director | 2023-02-13 21:02:04 | 44,000 0 | 44,000 | Form 4 |
SBLENDORIO GLENN Director | 2025-02-24 18:58:30 | 32,900 0 | 32,900 | Form 4 |
Karydas Daphne Director | 2025-02-24 18:58:41 | 32,900 0 | 32,900 | Form 4 |
Gold Alexander M Director | 2025-02-24 18:59:02 | 32,900 0 | 32,900 | Form 4 |
DiRocco Derek Director | 2025-02-24 18:59:12 | 32,900 0 | 32,900 | Form 4 |
Litzka Olivier Director | 2024-05-23 16:20:51 | 22,000 0 | 22,000 | Form 4 |
Takahashi Takeshi Director | 2023-07-14 08:55:32 | 0 0 | 0 | Form 4 |